TY  - RPRT
TI  - Ex Vivo Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A Viruses
AU  - Meineke, R.
AU  - Stelz, S.
AU  - Busch, M.
AU  - Werlein, C.
AU  - Kuehnel, M. P.
AU  - Jonigk, D.
AU  - Rimmelzwaan, G. F.
AU  - Elbahesh, H.
PY  - 2022
DO  - 10.1101/2022.01.19.476993
UR  - https://www.biorxiv.org/content/10.1101/2022.01.19.476993v1
ID  - 10.1101/2022.01.19.476993
ER  -